Alexia Bertuzzi

4.7k total citations · 1 hit paper
80 papers, 2.6k citations indexed

About

Alexia Bertuzzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alexia Bertuzzi has authored 80 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alexia Bertuzzi's work include Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (13 papers) and COVID-19 and healthcare impacts (11 papers). Alexia Bertuzzi is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (13 papers) and COVID-19 and healthcare impacts (11 papers). Alexia Bertuzzi collaborates with scholars based in Italy, United States and United Kingdom. Alexia Bertuzzi's co-authors include G. Iapichino, Jan–Dirk Studt, Luca Carenzo, Corrado Lodigiani, Maurizio Cecconi, Tim Sebastian, Clara Sacco, Stefano Barco, Nils Kucher and Paola Ferrazzi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Alexia Bertuzzi

71 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

2020 1.4k citations Alexia Bertuzzi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexia Bertuzzi Italy	19	1.2k	985	755	744	435	80	2.6k
Wolfgang Miesbach Germany	27	341 0.3×	511 0.5×	202 0.3×	229 0.3×	332 0.8×	192	3.2k
Haiyan Liu United States	16	738 0.6×	700 0.7×	365 0.5×	416 0.6×	119 0.3×	25	1.8k
Jan–Dirk Studt Switzerland	23	1.3k 1.1×	562 0.6×	780 1.0×	180 0.2×	651 1.5×	65	2.8k
Florian Moik Austria	21	265 0.2×	585 0.6×	257 0.3×	270 0.4×	1.2k 2.7×	66	2.0k
Daniel P. Hart United Kingdom	26	313 0.3×	490 0.5×	215 0.3×	132 0.2×	131 0.3×	58	2.9k
Vijaya Raj Bhatt United States	26	110 0.1×	1.4k 1.4×	140 0.2×	371 0.5×	194 0.4×	245	3.2k
Florian Posch Austria	31	140 0.1×	1.2k 1.2×	92 0.1×	675 0.9×	1.3k 2.9×	136	3.6k
Sean M. Devlin United States	33	177 0.1×	1.6k 1.6×	149 0.2×	197 0.3×	110 0.3×	269	4.0k
Guillermo J. Ruíz‐Argüelles Mexico	30	138 0.1×	521 0.5×	76 0.1×	238 0.3×	163 0.4×	307	3.2k
Monia Marchetti Italy	33	87 0.1×	505 0.5×	131 0.2×	240 0.3×	184 0.4×	113	3.3k

Countries citing papers authored by Alexia Bertuzzi

Since Specialization

Citations

This map shows the geographic impact of Alexia Bertuzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexia Bertuzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexia Bertuzzi more than expected).

Fields of papers citing papers by Alexia Bertuzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexia Bertuzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexia Bertuzzi. The network helps show where Alexia Bertuzzi may publish in the future.

Co-authorship network of co-authors of Alexia Bertuzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Alexia Bertuzzi. A scholar is included among the top collaborators of Alexia Bertuzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexia Bertuzzi. Alexia Bertuzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lavezzi, Elisabetta, Alessandro Brunetti, Emanuela Morenghi, et al.. (2025). Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort study. Endocrine Related Cancer. 32(9).

Pozzi, Chiara, Antonino Lo Cascio, Stefanos Bonovas, et al.. (2025). PV-1: a novel molecular prognostic marker of distant metastases in various solid tumors. EMBO Molecular Medicine. 17(9). 2215–2232.

Rossi, Roberta, Roberta Maselli, Silvia Carrara, et al.. (2025). Management of type I gastric-neuroendocrine tumors: the less the better?. Frontiers in Endocrinology. 16. 1666699–1666699.

Ruspi, Laura, Federico Sicoli, Salvatore Lorenzo Renne, et al.. (2024). Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios. Cancers. 16(17). 2965–2965. 2 indexed citations

Facciorusso, Antonio, Matteo Colombo, Kareem Khalaf, et al.. (2024). Preliminary data from a multicenter Italian study: use of EUS-Elastography and Contrast in the differential diagnosis of SELs. Endoscopy. 56(S 02). S104–S105.

Bertuzzi, Alexia, Laura Giordano, Nicolò Gennaro, et al.. (2023). Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high‐volume cancer center. Cancer Medicine. 12(15). 16254–16263. 1 indexed citations

Renne, Salvatore Lorenzo, Piergiuseppe Colombo, Laura Giordano, et al.. (2023). Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study. Human Pathology. 143. 17–23.

Rossi, Roberta, Elisabetta Lavezzi, Gennaro Nappo, et al.. (2023). Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art. Cancers. 15(16). 4065–4065. 2 indexed citations

Maso, Luigino Dal, Armando Santoro, Paolo De Paoli, et al.. (2022). Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group. Cancer Management and Research. Volume 14. 3105–3118. 11 indexed citations

10.

Cortellini, Alessio, Ramón Salazar, Mark Bower, et al.. (2022). Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer. British Journal of Cancer. 127(10). 1787–1792. 5 indexed citations

11.

Azzolini, Elena, Chiara Pozzi, Luca Germagnoli, et al.. (2022). mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients. Life Science Alliance. 5(6). e202201381–e202201381. 22 indexed citations

12.

Navarria, Pierina, Elena Clerici, Luca Cozzi, et al.. (2022). Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 114(4). 762–770. 14 indexed citations

13.

Bertuzzi, Alexia, Andrea Marrari, Nicolò Gennaro, et al.. (2020). Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy. Cancers. 12(9). 2352–2352. 22 indexed citations

14.

Gennaro, Nicolò, Andrea Marrari, Alexia Bertuzzi, et al.. (2020). The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic. Clinical Imaging. 70. 49–50. 8 indexed citations

15.

Bhatt, Nikita, Sandra Deady, Amy Gillis, et al.. (2015). Epidemiological study of soft‐tissue sarcomas in Ireland. Cancer Medicine. 5(1). 129–135. 9 indexed citations

16.

Sanctis, Rita De, Andrea Marrari, Silvia Marchetti, et al.. (2015). Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma. Drug Design Development and Therapy. 9. 5785–5785. 30 indexed citations

17.

Santoro, Armando, Alessandro Comandone, Umberto Basso, et al.. (2012). Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy. Annals of Oncology. 24(4). 1093–1098. 48 indexed citations

18.

Bertuzzi, Alexia, Luca Castagna, Vittorio Quagliuolo, et al.. (2003). Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour. British Journal of Cancer. 89(7). 1159–1161. 22 indexed citations

19.

Magagnoli, Massimo, Luca Castagna, Monica Balzarotti, et al.. (2003). Feasibility and toxicity of high‐dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non‐Hodgkin's lymphoma: Survey from a single institution. American Journal of Hematology. 73(4). 267–272. 11 indexed citations

20.

Balzarotti, Monica, Michele Spina, Barbara Sarina, et al.. (2002). Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology. 13(9). 1341–1346. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact